{"id":"https://openalex.org/W2106800134","doi":null,"title":"Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.","display_name":"Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2106800134","mag":"2106800134","pmid":"https://pubmed.ncbi.nlm.nih.gov/10667462"},"language":"en","primary_location":{"id":"pmid:10667462","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10667462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://escholarship.org/uc/item/4k66t6k4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018753315","display_name":"William B. Armstrong","orcid":"https://orcid.org/0000-0003-0672-4483","observed_orcids":["https://orcid.org/0000-0003-0672-4483"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4390039238","display_name":"UC Irvine Chao Family Comprehensive Cancer Center","ror":"https://ror.org/05gzqy922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W B Armstrong","raw_affiliation_strings":["Department of Otolaryngology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange 92868, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Otolaryngology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange 92868, USA","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4390039238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075478892","display_name":"Ann R. Kennedy","orcid":"https://orcid.org/0000-0002-1602-2015","observed_orcids":["https://orcid.org/0000-0002-1602-2015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A R Kennedy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014032746","display_name":"X. Steven Wan","orcid":"https://orcid.org/0000-0002-3801-6409","observed_orcids":["https://orcid.org/0000-0002-3801-6409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X S Wan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074284227","display_name":"Joshua O. Atiba","orcid":"https://orcid.org/0009-0006-8644-5909","observed_orcids":["https://orcid.org/0009-0006-8644-5909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Atiba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103071787","display_name":"Christine E. McLaren","orcid":"https://orcid.org/0000-0002-7932-9903","observed_orcids":["https://orcid.org/0000-0002-7932-9903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C E McLaren","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060872059","display_name":"Frank Louis Meyskens","orcid":"https://orcid.org/0000-0002-8827-4334","observed_orcids":["https://orcid.org/0000-0002-8827-4334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F L Meyskens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9015,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.95942029,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"43","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/3506","display_name":"Periodontics"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11452","display_name":"Oral Health Pathology and Treatment","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/3506","display_name":"Periodontics"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bowman-birk-inhibitor","display_name":"Bowman-Birk inhibitor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/serine-protease-inhibitors","display_name":"serine protease inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/oral-leukoplakia","display_name":"oral leukoplakia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.8820000290870667},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/single-dose-administration","display_name":"single-dose administration","score":0.6869999766349792},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7160000205039978},{"id":"https://openalex.org/keywords/toxicity","display_name":"toxicity","score":0.6620000004768372},{"id":"https://openalex.org/keywords/buccal-cells","display_name":"buccal epithelial cells","score":0.6909999847412109},{"id":"https://openalex.org/keywords/proteolytic-activity","display_name":"proteolytic activity","score":0.9290000200271606},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7011094689369202},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6826571822166443},{"id":"https://openalex.org/C195735259","wikidata":"https://www.wikidata.org/wiki/Q16963239","display_name":"Buccal administration","level":2,"score":0.6503714323043823},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.629263699054718},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5282142758369446},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.5177227854728699},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5111210942268372},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.465057909488678},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42268800735473633},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.41243886947631836},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3385160565376282},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31577515602111816},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1586892008781433},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.14876613020896912},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08105871081352234},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07849401235580444},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002918","descriptor_name":"Chymotrypsin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007972","descriptor_name":"Leukoplakia, Oral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009061","descriptor_name":"Mouth Mucosa","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D010450","descriptor_name":"Endopeptidases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014358","descriptor_name":"Trypsin Inhibitor, Bowman-Birk Soybean","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014358","descriptor_name":"Trypsin Inhibitor, Bowman-Birk Soybean","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014358","descriptor_name":"Trypsin Inhibitor, Bowman-Birk Soybean","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014358","descriptor_name":"Trypsin Inhibitor, Bowman-Birk Soybean","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014358","descriptor_name":"Trypsin Inhibitor, Bowman-Birk Soybean","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D014361","descriptor_name":"Trypsin Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014361","descriptor_name":"Trypsin Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014361","descriptor_name":"Trypsin Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014361","descriptor_name":"Trypsin Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014361","descriptor_name":"Trypsin Inhibitors","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D018890","descriptor_name":"Chemoprevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"pmid:10667462","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10667462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt4k66t6k4","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/4k66t6k4","pdf_url":"https://escholarship.org/uc/item/4k66t6k4","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 9, iss 1","raw_type":"article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt73z795dz","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/73z795dz","pdf_url":"https://escholarship.org/uc/item/73z795dz","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Epidemiology Biomarkers & Prevention, vol 9, iss 1","raw_type":"article"},{"id":"pmh:qt73z795dz","doi":null,"is_oa":true,"landing_page_url":"http://www.escholarship.org/uc/item/73z795dz","pdf_url":"http://www.escholarship.org/uc/item/73z795dz","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Armstrong, WB; Kennedy, AR; Wan, XS; Atiba, J; McLaren, CE; & Meyskens, FL. (2000). Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 9(1), 43 - 47. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/73z795dz","raw_type":"article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt73z795dz","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/73z795dz","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 9, iss 1","raw_type":"article"},{"id":"mag:2106800134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10667462","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:escholarship.org/ark:/13030/qt4k66t6k4","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/4k66t6k4","pdf_url":"https://escholarship.org/uc/item/4k66t6k4","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol 9, iss 1","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2871246162","display_name":"CANCER PREVENTION BY PROTEASE INHIBITORS","funder_award_id":"5u01ca046496-06","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000877839","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA062203","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2106800134.pdf","grobid_xml":"https://content.openalex.org/works/W2106800134.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W103425298","https://openalex.org/W251103412","https://openalex.org/W1245749104","https://openalex.org/W1505006275","https://openalex.org/W1506400459","https://openalex.org/W1523161496","https://openalex.org/W1756879316","https://openalex.org/W1828342189","https://openalex.org/W1956046742","https://openalex.org/W1969010440","https://openalex.org/W1978217306","https://openalex.org/W1980776206","https://openalex.org/W1986590322","https://openalex.org/W1987882207","https://openalex.org/W1988345161","https://openalex.org/W1998890155","https://openalex.org/W2001311961","https://openalex.org/W2002664886","https://openalex.org/W2004636370","https://openalex.org/W2014646550","https://openalex.org/W2015676158","https://openalex.org/W2036704097","https://openalex.org/W2040828656","https://openalex.org/W2046664793","https://openalex.org/W2049619765","https://openalex.org/W2053498187","https://openalex.org/W2054667699","https://openalex.org/W2054710139","https://openalex.org/W2064908131","https://openalex.org/W2071684198","https://openalex.org/W2071909821","https://openalex.org/W2091115314","https://openalex.org/W2103317140","https://openalex.org/W2128635872","https://openalex.org/W2145750969","https://openalex.org/W2169104376","https://openalex.org/W2171287413","https://openalex.org/W2324721986","https://openalex.org/W2411287195"],"related_works":["https://openalex.org/W1768203322","https://openalex.org/W2081244769","https://openalex.org/W2051919785","https://openalex.org/W2108331987","https://openalex.org/W2168387882","https://openalex.org/W1983206035","https://openalex.org/W2360313218","https://openalex.org/W144098005","https://openalex.org/W2018062749","https://openalex.org/W1994836178"],"abstract_inverted_index":{"The":[0],"Bowman-Birk":[1],"inhibitor":[2,9,59],"(BBI)":[3],"is":[4,138],"a":[5,11,29,66,76,113],"soybean-derived":[6],"serine":[7],"protease":[8],"and":[10,44,56,75,126],"potential":[12],"cancer":[13],"chemopreventive":[14],"agent":[15],"for":[16,49],"humans.":[17],"In":[18],"this":[19],"Phase":[20,134],"I":[21],"clinical":[22,90,136],"trial,":[23],"BBI":[24,41,70,80,116],"concentrate":[25,117],"was":[26,42,71,81,96,103,123],"administered":[27,118],"as":[28,112],"single":[30],"oral":[31,37],"dose":[32,67],"to":[33,109,120,128],"24":[34],"subjects":[35,45],"with":[36],"leukoplakia.":[38],"Pharmacokinetics":[39],"of":[40,62,79,94],"analyzed,":[43],"were":[46],"monitored":[47],"clinically":[48],"toxic":[50],"effects.":[51],"Subjects":[52],"received":[53],"between":[54],"25":[55],"800":[57,121],"chymotrypsin":[58],"units":[60],"(CIU)":[61],"the":[63,84,99],"compound":[64],"in":[65,83,98,106,133],"escalation":[68],"trial.":[69],"taken":[72],"up":[73,119],"rapidly,":[74],"metabolic":[77],"product":[78],"excreted":[82],"urine":[85],"within":[86],"24-48":[87],"h.":[88],"No":[89],"or":[91],"laboratory":[92],"evidence":[93],"toxicity":[95],"observed":[97],"study.":[100],"Protease":[101],"activity":[102],"also":[104],"measured":[105],"buccal":[107],"cells":[108],"evaluate":[110],"usefulness":[111],"biomarker.":[114],"Single-dose":[115],"CIU":[122],"well":[124],"tolerated":[125],"appeared":[127],"be":[129],"nontoxic.":[130],"Further":[131],"investigation":[132],"II":[135],"trials":[137],"being":[139],"done.":[140]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}